NCT03599076

Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease Huntington's Disease

Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: BioSensics · Industry
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

The principal means of measuring motor impairment in Huntington disease (HD) is the Unified Huntington's Disease Rating Scale (UHDRS) total motor score, which is subjective, categorical, requires significant training to administer correctly, and only captures impairments in clinic. In this Direct to Phase II SBIR we will develop a wearable sensor system for objective, sensitive, and continuous assessment of Huntington's chorea during activities of daily living. The developed technology could be used clinically to detect changes in motor function in response to medications, or could be used scientifically to expedite and reduce the cost of early stage pharmaceutical clinical trials.

Conditions

• Huntington Disease

Interventions

Type	Name	Description
OTHER	HD Wear	Wearable sensor system for monitoring Huntington's chorea during activities of daily living

Timeline

• Start date: 2018-09-25
• Primary completion: 2019-12-01
• Completion: 2019-12-01
• First posted: 2018-07-26
• Last updated: 2019-01-24

Locations

1 site across 1 country: United States